Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens

CMAJ. Canadian Medical Association Journal

Volumn 160, Issue 5, 1999, Pages 659-665

  Hogg, Robert S ^a,d   Yip, Benita ^a   Kully, Charlotte ^a   Craib, Kevin J P ^a   O'Shaughnessy, Michael V ^a,b,c   Schechter, Martin T ^a,b,c   Montaner, Julio S G ^a,b,c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Canadian HIV Trials Network   (Canada)

^d Brit Columbia Ctr E   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANADA; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIOSIS; PNEUMOCYSTIS PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL;

EID: 0033537620     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitahine. AIDS Clinical Trials Group. N Engl J Med 1996;334:1011-7.
2. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzales C, McMahon D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and priorantiretrovial therapy. N Engl J Med 1997;337:734-9.
3. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.
4. Cameron DW, Heath-Chiozzi M, Danner S, Cohen C, Kravcik S, Maurath C, et al. Randomized placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet 1998;351:543-9.
5. Montaner JS, Reiss P, Cooper D, Vella S, Harris M, Conway B, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected variants. The INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA 1998;279:930-7.
6. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV infected adults and adolescents. Washington: US Department of Health and Human Services; 1997 Nov 5.
7. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society - USA Panel. JAMA 1998;280:78-86.
8. BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997;349:1086-92.
9. Therapeutic guidelines for the treatment of HIV/AIDS and related conditions. Vancouver: British Columbia Centre for Excellence in HIV/AIDS; 1995.
10. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;279:450-4.
11. Hogg RS, O'Shaughnessy MV, Gataric N, Yip B, Craib K, Schechter MT, et al. Decline in deaths from AIDS due to new antiretrovirals [letter]. Lancet 1997;349:1294.
12. Hogg RS, Rhone SA, Yip B, Sherlock C, Conway B, Schechter MT, et al. Antiviral effect of double and triple drug combinations amongst HIV-infected adults: lessons from the implementation of viral load-driven antiretroviral therapy. AIDS 1998;12:279-84.
13. World Health Organization. Acquired immune deficiency syndrome (AIDS): interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Res 1990;65:221-8.
14. Centers for Disease Control. 1993 revised classification system for HIV-infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(RR-17):1-19.
15. Neave HR, Worthington PL. Distribution-free tests. London: Routledge; 1998.
16. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-202.
17. Pallela FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
18. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998;280:547-9.
19. Hogg RS, Strathdee SA, Craib KJP, O'Shaughnessy MV, Montaner JSG, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet 1994;344:1120-4.